Cord Blood America, Inc. (OTCBB: CBAI), an umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced last week that it had retired $2.53 million of long term debt. The debt was related to the company's acquisition of CorCell, the first licensed family cord blood banking company in the United States which allowed the company to establish itself as one of the largest domestic stem cell storage companies. The notes were scheduled to mature on February 28, 2010 and were paid off ahead of schedule as part of the company's plan to increase shareholder value by strengthening its balance sheet through retiring debt. Shares remained unchanged at less than a penny on the week.